Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$216,185
-$60,017 QoQ
Shares Held
597
-23.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,807
of 3,140 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $2,738,678 across 11 Drug Manufacturers - General names. AMGN ranks #6 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
833 | $999,123 | |
| 2 | NVO |
Novo Nordisk A S
|
8,881 | $425,755 | |
| 3 | ABBV |
AbbVie Inc.
|
1,197 | $301,212 | |
| 4 | PFE |
Pfizer Inc
|
9,522 | $229,288 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,760 | $226,160 | |
| 6 | AMGN |
Amgen Inc
This page
|
597 | $216,185 | |
| 7 | AZN |
Astrazeneca PLC
|
1,049 | $198,911 | |
| 8 | JNJ |
Johnson & Johnson
|
336 | $85,333 |
All Filings in AMGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $216,185 | 597 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $276,202 | 785 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $202,931 | 620 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $211,932 | 751 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $205,218 | 735 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $574,185 | 1,843 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $561,417 | 2,154 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $246,812 | 766 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $133,076,203 | 425,912 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $78,313,384 | 275,441 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $713,712 | 2,478 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $805,204 | 2,996 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $761,978 | 3,462 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6 | 28 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $78,394,362 | 298,486 | Shares | Defined | 2023-02-13 | |
| 2022-03-31 | $26,116 | 108 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $39,144 | 174 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $34,449 | 162 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $30,468 | 125 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $10,510,729 | 42,244 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,745,930 | 24,991 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,019,165 | 11,879 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $88,919 | 377 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||